Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Stock
Equities
RMDA
EGS381B1C015
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.35 EGP | +4.91% | +9.30% | +42.42% |
Sales 2024 * | 2.92B 61.79M | Sales 2025 * | 3.53B 74.82M | Capitalization | 3.5B 74.18M |
---|---|---|---|---|---|
Net income 2024 * | 388M 8.22M | Net income 2025 * | 534M 11.31M | EV / Sales 2024 * | 1.57 x |
Net Debt 2024 * | 1.07B 22.59M | Net Debt 2025 * | 766M 16.22M | EV / Sales 2025 * | 1.21 x |
P/E ratio 2024 * |
7.91
x | P/E ratio 2025 * |
6.04
x | Employees | - |
Yield 2024 * |
4.51% | Yield 2025 * |
7.49% | Free-Float | 50.28% |
1 day | +4.91% | ||
1 week | +9.30% | ||
1 month | +14.08% | ||
3 months | -18.97% | ||
6 months | +40.55% | ||
Current year | +42.42% |
Managers | Title | Age | Since |
---|---|---|---|
Amr Morsy
CEO | Chief Executive Officer | - | 10-12-31 |
Mahmoud Fayek
DFI | Director of Finance/CFO | - | 18-12-31 |
Rania Farouk
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Farida Khamis
BRD | Director/Board Member | - | 19-12-31 |
Director/Board Member | 65 | 18-12-31 | |
Director/Board Member | - | 10-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-30 | 2.35 | +4.91% | 2,380,457 |
24-05-29 | 2.24 | -1.32% | 11,186,560 |
24-05-28 | 2.27 | -3.40% | 4,563,469 |
24-05-27 | 2.35 | +3.52% | 19,050,990 |
24-05-26 | 2.27 | +5.58% | 5,344,436 |
End-of-day quote Egyptian Exchange, May 29, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+42.42% | 74.1M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- RMDA Stock